Form D — Platform Therapeutics, Inc.
0002152141-26-000001 · filed Aug 27, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $4,000,000
- Total sold
- $1,750,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Platform Therapeutics, Inc.
- CIK
- 2152141
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 300 BRICKSTONE SQUARE, STE 201
ANDOVER, MA 01810 - Phone
- 339-224-0265
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
JAMES WILKIE · Executive OfficerANDOVER, MA Find on LinkedIn ↗
-
LAKHMIR CHAWLA · DirectorANDOVER, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗